Aripiprazole
Arpixor contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
It is used to treat adults with a disease characterized by symptoms such as:
seeing, hearing, and feeling things that do not exist in reality, excessive suspicion,
beliefs that are inconsistent with reality, incoherent speech and behavior, and emotional numbness.
Patients with the above symptoms may also experience sadness, anxiety, or tension, as well as feelings of guilt.
Arpixor is used to treat adults whose disease is characterized by symptoms such as:
strong excitement, overflowing energy, reduced need for sleep, very fast speech, racing thoughts, and sometimes very severe irritability. In adults, this medicine also prevents the recurrence of the above symptoms in patients who have responded to Arpixor treatment.
During treatment with aripiprazole, suicidal thoughts and behaviors have been reported. You should immediately inform your doctor if you experience thoughts or feelings related to self-harm.
Before starting to take Arpixor, you should discuss this with your doctor if you have:
If you notice an increase in weight, unusual movements, drowsiness that interferes with daily activities, any difficulty swallowing, or signs of an allergic reaction, you should inform your doctor.
Arpixor may cause drowsiness, decreased blood pressure when standing up, dizziness, and changes in mobility and balance, which can lead to falls. You should be careful, especially if you are elderly or weakened.
If you are elderly and have dementia (loss of memory and other mental abilities), you or your caregiver or relative should inform your doctor if you have ever had a stroke or "mini-stroke".
You should immediately inform your doctor if you experience thoughts or feelings related to self-harm. During treatment with aripiprazole, suicidal thoughts and behaviors have been reported.
You should immediately inform your doctor if you experience muscle stiffness or stiffness with high fever, sweating, mental disorders, or very rapid or irregular heartbeat.
You should inform your doctor if you or your family/caregiver notice increased appetite or thirst, unusual behavior, impulse, actions that may harm you or others. These are so-called impulse control disorders and may include behaviors such as gambling, overeating, or excessive spending, abnormally high sexual desire, or being overly preoccupied with sexual thoughts or feelings.
Your doctor may adjust the dose or stop it.
Aripiprazole may cause drowsiness, decreased blood pressure when standing up, dizziness, and changes in mobility and balance, which can lead to falls. You should be careful, especially if you are elderly or weakened.
This medicine should not be used in children and adolescents.
You should tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take, including those that are available without a prescription.
Blood pressure-lowering medicines: Arpixor may enhance the effects of blood pressure-lowering medicines. If you are taking medicines to control blood pressure, you should inform your doctor.
Taking Arpixor with other medicines may require a change in the dose of Arpixor. It is especially important to inform your doctor about the use of the following medicines:
These medicines may increase the risk of side effects or decrease the effect of Arpixor. If you experience any unusual symptoms while taking any of these medicines with Arpixor, you should contact your doctor.
Medicines that increase serotonin levels are usually used in conditions such as depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
These medicines may increase the risk of side effects; if you experience any unusual symptoms while taking any of these medicines with Arpixor, you should contact your doctor.
Arpixor can be taken with or without food.
You should avoid drinking alcohol.
If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a baby, you should consult your doctor before taking this medicine.
In newborns whose mothers took Arpixor during the last trimester (last 3 months of pregnancy), the following symptoms may occur: trembling, muscle stiffness, and/or weakness, drowsiness, agitation, difficulty breathing, and difficulty feeding. If you notice any of these symptoms in your child, you should contact your doctor.
When taking Arpixor, your doctor will discuss with you whether you should breastfeed, taking into account the benefits of treatment and the benefits of breastfeeding. You should not do both. You should discuss with your doctor the best way to feed your child if you are taking this medicine.
While taking this medicine, seizures or vision problems may occur (see section 4).
You should not drive, use tools, or operate any machinery until you know how Arpixor affects you.
If you have been diagnosed with an intolerance to some sugars, you should inform your doctor before taking this medicine.
This medicine should always be taken exactly as your doctor or pharmacist has told you. If you are not sure, you should ask your doctor or pharmacist.
The recommended dose of Arpixor for adults is 15 mg once a day.However, your doctor may prescribe a lower or higher dose, which should not exceed 30 mg once a day.
If you feel that the effect of Arpixor is too strong or too weak, you should consult your doctor or pharmacist.
Arpixor 10 mg, 20 mg, and 30 mg: the tablet can be divided into equal doses.
Arpixor 15 mg: the score line is not intended for breaking the tablet.
Arpixor should be taken once a day at the same time.It does not matter whether the tablet is taken with or without food.
The tablet should be swallowed whole and washed down with water.
Even if you feel better, you should not change the dose or stop taking Arpixor without first discussing it with your doctor.
If you have taken more Arpixor tablets than your doctor recommended (or if someone else has taken some of the Arpixor tablets that were not intended for them), you should immediately contact your doctor or go to the nearest hospital, taking the packaging of the medicine with you.
Patient who have taken aripiprazole may experience the following symptoms:
Other symptoms may include:
If you experience any of the above symptoms, you should immediately contact your doctor or pharmacist.
If you miss a dose, you should take the missed dose as soon as you remember. You should not take two doses on the same day.
You should not stop taking Arpixor even if you feel better. It is important to continue taking Arpixor for as long as your doctor has prescribed.
If you have any further questions about the use of this medicine, you should ask your doctor or pharmacist.
In elderly patients with dementia, taking aripiprazole has been associated with a higher number of deaths. Additionally, cases of stroke or "mini-stroke" have been reported.
If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor or pharmacist.
Side effects can be reported directly to:
Department for Monitoring of Adverse Reactions to Medicinal Products
Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C, 02-222 Warsaw,
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after: EXP.
The expiry date refers to the last day of the month.
The batch number is stated after the abbreviation: Lot
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Arpixor, 5 mg: Oblong, biconvex tablets with the inscription "C1" on one side, with a main diameter of 8.5 ± 0.3 mm and a minor diameter of 5.0 ± 0.3 mm.
Arpixor 10 mg: Oblong, biconvex tablets with the inscription "C2" on one side, with a main diameter of 8.5 ± 0.3 mm and a minor diameter of 5.0 ± 0.3 mm.
Arpixor, 15 mg: Round, biconvex tablets with the inscription "C3" on one side and a diameter of 7.5 ± 0.3 mm.
Arpixor, 20 mg: Round, biconvex tablets with a score line, with a diameter of 8.5 ± 0.3 mm.
Arpixor, 30 mg: Round, biconvex tablets with the inscription "C7" on one side and a diameter of 10.0 ± 0.3 mm.
Arpixor is available in blisters /Aluminum/PVC/Aluminum/OPA, packed in cardboard boxes containing 14, 28, or 56 tablets.
Not all pack sizes may be marketed.
neuraxpharm Arzneimittel GmbH
Elisabeth-Selbert-Str. 23
40764 Langenfeld
Germany
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona 69
08970 Sant Joan Despí (Barcelona), Spain
To obtain more detailed information, you should contact the representative of the marketing authorization holder
in Poland:
Neuraxpharm Polska sp. z o.o.
Domaniewska 37
02-672 Warsaw
info-poland@neuraxpharm.com
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.